Benitec Biopharma (BNTC) Change in Account Payables (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Change in Account Payables for 7 consecutive years, with $484000.0 as the latest value for Q2 2025.

  • Quarterly Change in Account Payables fell 68.63% to $484000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Jun 2025, down 352.71% year-over-year, with the annual reading at -$2.4 million for FY2025, 352.71% down from the prior year.
  • Change in Account Payables hit $484000.0 in Q2 2025 for Benitec Biopharma, up from -$3.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.6 million in Q1 2021 to a low of -$3.8 million in Q1 2025.
  • Historically, Change in Account Payables has averaged $82888.9 across 5 years, with a median of $533000.0 in 2022.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 376.95% in 2021 and later plummeted 466.51% in 2024.
  • Year by year, Change in Account Payables stood at $853000.0 in 2021, then tumbled by 164.48% to -$550000.0 in 2022, then surged by 307.45% to $1.1 million in 2023, then increased by 14.11% to $1.3 million in 2024, then tumbled by 62.83% to $484000.0 in 2025.
  • Business Quant data shows Change in Account Payables for BNTC at $484000.0 in Q2 2025, -$3.8 million in Q1 2025, and $1.3 million in Q4 2024.